waystore9
About
Switching coming from blonanserin oral tablets/powders to transdermal spots alleviates extrapyramidal signs within people with schizophrenia: Any 52-week open-label study.
Switching coming from blonanserin oral tablets/powders to transdermal spots alleviates extrapyramidal signs within people with schizophrenia: Any 52-week open-label study.